These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 6924817)

  • 41. Prekallikrein, HMW-kininogen and factor XII in various disease states.
    Deutsch E; Dragosics B; Kopsa H; Mannhalter C; Rainer H
    Thromb Res; 1983 Jul; 31(2):351-64. PubMed ID: 6356459
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hyperprolactinemia and reduction in plasma titers of Hageman factor, prekallikrein, and high molecular weight kininogen in patients with acute myocardial infarction.
    La Follette L; Gordon EM; Mazur CA; Ratnoff OD; Yamashita TS
    J Lab Clin Med; 1987 Sep; 110(3):318-21. PubMed ID: 3649393
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Clinical significance of factor XII analysis in blood coagulation tests].
    Saito H
    Nihon Rinsho; 1989 Dec; 48 Suppl():843-5. PubMed ID: 2622016
    [No Abstract]   [Full Text] [Related]  

  • 44. Kinin activation as a predictive assay for adverse reactions to radiographic contrast medium.
    Carr DH; Walker AC
    Acta Radiol Diagn (Stockh); 1984; 25(4):337-42. PubMed ID: 6567445
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Determination of prekallikrein in plasma by means of a chromogenic tripeptide substrate for plasma kallikrein.
    Friberger P; Eriksson E; Gustavsson S; Claeson G
    Adv Exp Med Biol; 1979; 120A():67-82. PubMed ID: 40406
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Effect of various infusion media and solutions on the kallikrein-kinin system of human plasma].
    Dotsenko VL; Morozova NA; Iarovaia GA
    Vopr Med Khim; 1985; 31(4):116-21. PubMed ID: 3931350
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A pre-albumin activator of prekallikrein.
    Kaplan AP; Austen KF
    J Immunol; 1970 Oct; 105(4):802-11. PubMed ID: 5470521
    [No Abstract]   [Full Text] [Related]  

  • 48. Description and evaluation of a new chromogenic substrate assay kit for the determination of prekallikrein in human plasma.
    Friberger P; Gallimore MJ
    Adv Exp Med Biol; 1986; 198 Pt B():543-8. PubMed ID: 3643742
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prekallikrein deficiency in a dog.
    Chinn DR; Dodds WJ; Selcer BA
    J Am Vet Med Assoc; 1986 Jan; 188(1):69-71. PubMed ID: 3632973
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Plasma prekallikrein: determination using a chromogenic substrate. Studies of clinico-diagnostic relevance].
    Bruhn HD
    Internist (Berl); 1983 Apr; 24(4):220-5. PubMed ID: 6345439
    [No Abstract]   [Full Text] [Related]  

  • 51. [Micromethod for determining prekallikrein in blood plasma using a chromogenic substrate].
    Kuznetsov VA
    Lab Delo; 1985; (7):400-2. PubMed ID: 2414517
    [No Abstract]   [Full Text] [Related]  

  • 52. [Plasma factor XII (Hageman factor) in disease states (author's transl)].
    Ichinose A; Maruyama I; Imaguma M; Sonoda T; Igata A
    Rinsho Ketsueki; 1981 Aug; 22(8):1232-6. PubMed ID: 7328776
    [No Abstract]   [Full Text] [Related]  

  • 53. A new assay for the determination of factor XII in plasma using a chromogenic substrate and a selective inhibitor of plasma kallikrein.
    Stürzebecher J; Svendsen L; Eichenberger R; Markwardt F
    Thromb Res; 1989 Sep; 55(6):709-15. PubMed ID: 2781533
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Contact factor deficiencies and cardiopulmonary bypass surgery: detection of the defect and monitoring of heparin.
    van Veen JJ; Laidlaw S; Swanevelder J; Harvey N; Watson C; Kitchen S; Makris M
    Eur J Haematol; 2009 Mar; 82(3):208-12. PubMed ID: 19077049
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Reduction of contact factors in sickle cell disease.
    Gordon EM; Klein BL; Berman BW; Strandjord SE; Simon JE; Coccia PF
    J Pediatr; 1985 Mar; 106(3):427-30. PubMed ID: 3844465
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Plasma levels of factor XII, prekallikrein and high molecular weight kininogen in normal blood donors and patients having suffered venous thrombosis.
    Gallimore MJ; Harris SL; Jones DW; Winter M
    Thromb Res; 2004; 114(2):91-6. PubMed ID: 15306150
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The amidolytic prekallikrein (PK) determination: enhanced PK activation after deep-freezing of patients' plasmas.
    Lämmle B; Tran TH
    Thromb Haemost; 1983 Jun; 49(3):249. PubMed ID: 6554024
    [No Abstract]   [Full Text] [Related]  

  • 58. Factor XII does not initiate prekallikrein activation on endothelial cells.
    Røjkjaer R; Hasan AA; Motta G; Schousboe I; Schmaier AH
    Thromb Haemost; 1998 Jul; 80(1):74-81. PubMed ID: 9684789
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [A study of coagulation contact factors in hereditary angioneurotic oedema (author's transl)].
    Soulier JP; Gozin D; Ollier-Hartmann MP; Hartmann L
    Nouv Presse Med; 1981 May; 10(20):1627-31. PubMed ID: 6166918
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mechanism of activation of the kallikrein-kinin system in plasma of patients with atopic allergic diseases.
    Dotsenko VL; Nenasheva NM; Neshkova EA; Morozova NA; Yarovaya GA
    Adv Exp Med Biol; 1989; 247B():515-21. PubMed ID: 2610090
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.